GEK TERNA Holdings Real Estate Construction S.A (GEKTERNA)
Athens Exchange · Greece · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 38.96 |
|---|---|
| 52-week range | 22.50 – 48.32 |
| Return, 1 month / 3 months | −9.0% / −10.3% |
| Return, 1 year / 3 years | +72.1% / +213.9% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -17.6% |
| Average daily value traded | 15.07M EUR |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
GEK TERNA Holdings Real Estate Construction is a Greek group based in Athens that works across construction, concessions and energy. It builds infrastructure such as roads, bridges and buildings for public and private clients, and it develops and operates power generation, including renewable energy projects. The company also takes part in concession arrangements for transport infrastructure and holds real estate interests, serving customers and public authorities mainly in Greece and neighbouring markets.
On this site GEK TERNA Holdings Real Estate Construction S.A appears as a stock on the Athens Exchange (Greece), code GEKTERNA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
GEK TERNA Holdings Real Estate Construction S.A (GEKTERNA) trades on the Athens Exchange in Greece. It last closed at EUR 38.96 on 22 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 45 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 72.1% and over the last three months it fell 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.4% | ||
| From 52-week high | -17.4% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.3% | ||
| 6-month return | -4.6% | ||
| 12-month return, skipping the last month | 89.1% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.6% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 15.07M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −9.0% |
| 3 months | −10.3% |
| 6 months | −4.6% |
| 1 year | +72.1% |
| 3 years | +213.9% |
| 5 years | +322.4% |
Signals
| 50-day / 200-day average | 43.28 / 39.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.23 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | EUR 0.4092 |
| 25 Jun 2025 | EUR 0.4134 |
| 28 Aug 2024 | EUR 0.2500 |
| 23 Aug 2023 | EUR 0.2000 |
| 6 Sep 2022 | EUR 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.